JEMNX
Price
$9.14
Change
-$0.23 (-2.45%)
Updated
Apr 3 closing price
Net Assets
1.25B
RNWEX
Price
$76.48
Change
-$1.86 (-2.37%)
Updated
Apr 3 closing price
Net Assets
62.34B
Ad is loading...

JEMNX vs RNWEX

Header iconJEMNX vs RNWEX Comparison
Open Charts JEMNX vs RNWEXBanner chart's image
JHancock Emerging Markets Equity R4
Price$9.14
Change-$0.23 (-2.45%)
VolumeN/A
Net Assets1.25B
American Funds New World R4
Price$76.48
Change-$1.86 (-2.37%)
VolumeN/A
Net Assets62.34B
JEMNX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEMNX vs. RNWEX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEMNX is a Buy and RNWEX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 62.3B vs. JEMNX (1.25B). RNWEX pays higher dividends than JEMNX: RNWEX (0.89) vs JEMNX (0.36). JEMNX was incepted earlier than RNWEX: JEMNX (10 years) vs RNWEX (23 years). JEMNX (1.42) is less costly to investors than RNWEX (0.92). JEMNX is a more actively managed with annual turnover of: 46.00 vs. RNWEX (37.00). JEMNX has a lower initial minimum investment than RNWEX: JEMNX (0) vs RNWEX (250). JEMNX annual gain was more profitable for investors over the last year : 1.54 vs. RNWEX (-1.81). RNWEX return over 5 years is better than : 49.22 vs. JEMNX (9.51).
JEMNXRNWEXJEMNX / RNWEX
Total Expense Ratio1.160.92126%
Annual Report Gross Expense Ratio1.420.92154%
Fund Existence10 years23 years-
Gain YTD-1.056-0.0138,082%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.25B62.3B2%
Annual Yield % from dividends0.360.8941%
Returns for 1 year1.54-1.81-85%
Returns for 3 years-11.01-0.343,237%
Returns for 5 years9.5149.2219%
Returns for 10 yearsN/A40.47-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKDA2.800.13
+4.76%
Arcadia Biosciences
SLS1.100.01
+0.92%
SELLAS Life Sciences Group
NIO3.74-0.06
-1.58%
NIO Inc.
RAMP25.23-1.38
-5.19%
LiveRamp Holdings
CEVA22.55-3.66
-13.96%
CEVA